NCT01302132View on ClinicalTrials.gov

Mass Balance Study of ASP1941

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Healthy Subjects
Interventions
DRUG

ASP1941

Oral solution

Trial Locations (1)

9470 AE

Zuidlaren

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY